跳至主要内容
临床试验/CTRI/2025/07/089980
CTRI/2025/07/089980招募中2 期

Therapeutic evaluation of abzan of habb-ul-aas (Myrtus communis Linn.) in cervical erosion An Open Interventional Trial

State takmeel ut tib college and hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年7月12日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
Reduction in the subjective symptoms

研究概览

简要总结

Patients meeting all the inclusion criteria will be given test drug daily in the morning for 14days. During treatment patients are advised to avoid sexual intercourse. Clinical parameters will be assessed on each visit.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Married women above 18 years Cervical erosion on P/S examination Normal/Inflammatory changes on Pap’s smear.

排除标准

  • Pregnant, lactating and menopausal women Patients with systemic, endocrinal illness and history of malignancy Patients with sexually transmitted diseases Presence of abnormal growth on the cervix Patients with other pelvic pathology Patients on oral contraceptive pills and IUCDs.

结局指标

主要结局

Reduction in the subjective symptoms

时间窗: 14 days

Reduction in the cervical erosion score

时间窗: 14 days

Improvement in the quality of life (SF-12 score)

时间窗: 14 days

次要结局

  • Improvement in the quality of life (SF-12 score)(14 days)

研究者

发起方
State takmeel ut tib college and hospital
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Farheen Fatima

State takmeel ut tib college and hospital

研究点 (1)

Loading locations...

相似试验